Loading
Latest filing published 25 Jul 2025 for DiaMedica Therapeutics Inc., €4.6M. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
All filings by Jan Stahlberg on record concern DiaMedica Therapeutics Inc. In total, 4 filings cover trades dated from 28 June 2024 to 17 November 2025.
Purchases make up the whole of the open-market record (4 purchases, €9.9M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2025 alone, the filings show 3 purchases and no sales.
A typical purchase (the median) is worth €2.1M. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 8 December 2025, the filings show an open-market purchase worth €1.1M in DiaMedica Therapeutics Inc. Typically, a trade is published a median of 12 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations